Symbicort NDA On-Track Despite FDA Data Request, AstraZeneca Says

FDA has requested additional chemistry, manufacturing and control data for Symbicort inhalation delivery device. While AstraZeneca does not believe this will significantly delay product development, the company does have a back-up strategy for a slightly modified device.